Open innovation for new drug research in Indian pharmaceutical sector

Research output: Contribution to conferencePoster

Abstract

The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.

Conference

ConferenceDrug Discovery India 2014
CountryIndia
CityMumbai
Period11/09/1412/09/14

Fingerprint

India
Patents
Research
Pharmaceutical Preparations
Ecosystem
Industry
Innovation
Drugs
Pharmaceuticals
Open innovation
Influence factors
Innovation networks
Public research
TRIPS agreement
Paradigm shift
Government
Innovation strategy
Interlinkage
Patent protection
Amendments

Keywords

  • innovation
  • collaboration
  • pharmaceutics

Cite this

Bhatnagar, B., MacBryde, J., & Dörfler, V. (2014). Open innovation for new drug research in Indian pharmaceutical sector. Poster session presented at Drug Discovery India 2014, Mumbai, India.
@conference{b69dd7d1b58a446c8ca180bacc6e5e5e,
title = "Open innovation for new drug research in Indian pharmaceutical sector",
abstract = "The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.",
keywords = "innovation, collaboration, pharmaceutics",
author = "Bhawani Bhatnagar and Jillian MacBryde and Viktor D{\"o}rfler",
year = "2014",
month = "9",
day = "12",
language = "English",
note = "Drug Discovery India 2014 ; Conference date: 11-09-2014 Through 12-09-2014",

}

Bhatnagar, B, MacBryde, J & Dörfler, V 2014, 'Open innovation for new drug research in Indian pharmaceutical sector' Drug Discovery India 2014, Mumbai, India, 11/09/14 - 12/09/14, .

Open innovation for new drug research in Indian pharmaceutical sector. / Bhatnagar, Bhawani; MacBryde, Jillian; Dörfler, Viktor.

2014. Poster session presented at Drug Discovery India 2014, Mumbai, India.

Research output: Contribution to conferencePoster

TY - CONF

T1 - Open innovation for new drug research in Indian pharmaceutical sector

AU - Bhatnagar, Bhawani

AU - MacBryde, Jillian

AU - Dörfler, Viktor

PY - 2014/9/12

Y1 - 2014/9/12

N2 - The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.

AB - The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.

KW - innovation

KW - collaboration

KW - pharmaceutics

UR - http://selectbiosciences.com/conferences/index.aspx?conf=DDI14

M3 - Poster

ER -

Bhatnagar B, MacBryde J, Dörfler V. Open innovation for new drug research in Indian pharmaceutical sector. 2014. Poster session presented at Drug Discovery India 2014, Mumbai, India.